Abstract
We retrospectively studied whether treatment with esomeprazole improved HbA1c levels in type 2 diabetic patients. We selected 21 patients who had been treated with esomeprazole for 11±3 months and 21 controls. HbA1c levels decreased in the esomeprazole-treated group. Our data indicate that proton pump inhibitors may improve glycaemic control in type 2 diabetic patients.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetes Research and Clinical Practice |
Vol/bind | 90 |
Udgave nummer | 3 |
ISSN | 0168-8227 |
DOI | |
Status | Udgivet - 1 dec. 2010 |
Udgivet eksternt | Ja |